Ipamorelin alternatives.

10 compounds compared to Ipamorelin, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Why people look for an alternative

Ipamorelin is already the answer to a different alternatives search. It was characterized by Novo Nordisk researchers as the first GHRP-receptor agonist with selectivity for GH release approaching that of GHRH, which is why people move to it from the earlier GHRPs that also push cortisol, prolactin, or appetite. So anyone searching for an alternative to ipamorelin is usually after something the whole class lacks: approval. It is not approved by the FDA for any indication, was the subject of pharmacy-compounding review rather than drug approval, and is prohibited in sport by WADA at all times. Within the secretagogues, selectivity is the ceiling, not evidence.

What you're comparing against
Ipamorelin
F tier · 33/100Research / preclinical

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) belonging to the growth hormone-releasing peptide (GHRP) class, sometimes described as a "third-generation" GHRP.

Ranked by evidence · strongest first
  1. 01
    GHRP-1
    D tierResearch / preclinical
    growth hormone-releasing peptide-1

    Acts through the ghrelin-receptor agonism pathway, like Ipamorelin. Research / preclinical.

  2. 02
    GHRP-2
    D tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like Ipamorelin. Research / preclinical.

  3. 03
    GHRP-6
    D tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like Ipamorelin. Research / preclinical.

  4. 04
    Hexarelin
    D tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like Ipamorelin. Research / preclinical.

  5. 05
    Human Growth Hormone
    S tierFDA-approved
    HGH · somatropin

    Same category: growth hormone. FDA-approved.

  6. 06
    Tesamorelin
    A tierFDA-approved
    Egrifta

    Same category: growth hormone. FDA-approved.

  7. 07
    Sermorelin
    C tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  8. 08
    ACE-031
    D tierIn human trials
    ramatercept · ActRIIB-Fc

    Same category: growth hormone. In human trials.

  9. 09
    CJC-1295
    F tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  10. 10
    IGF-1 LR3
    F tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

How this list is built

An “alternative” here means a compound that shares Ipamorelin's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds